Igm Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
IGM Biosciences announces its 2024 Annual Meeting to be held on June 11, 2024, with key proposals including the election of directors, ratification of the accounting firm, liability limitations for officers, and a stock option exchange program.
IGM Biosciences announces its 2024 Annual Meeting of Stockholders to be held virtually on June 11, 2024, featuring proposals for director elections, auditor ratification, officer liability limitation, and a stock option exchange program.